Now showing items 1-1 of 1

    • Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy. 

      Prokopi, A; Tripp, CH; Tummers, B; Hornsteiner, F; Spoeck, S; Crawford, JC; Clements, DR; Efremova, M; Hutter, K; Bellmann, L (2021-01)
      BACKGROUND: Immunotherapy with checkpoint inhibitors has shown impressive results in patients with melanoma, but still many do not benefit from this line of treatment. A lack of tumor-infiltrating T cells is a common reason ...